Relay Therapeutics Signs Lease for New Kendall Square Office, Reducing Rent by $16 Million

Reuters
05 Jun
<a href="https://laohu8.com/S/RLAY">Relay Therapeutics</a> Signs Lease for New Kendall Square Office, Reducing Rent by $16 Million

Relay Therapeutics Inc. has announced the execution of a significant agreement with ARE MA Region No. 58, LLC, amending their existing lease arrangement for their laboratory and office space at 399 Binney Street, Cambridge, Massachusetts. Initially set to expire on April 30, 2029, the lease will now terminate early, contingent upon the possession of new premises under the Kendall Square Lease being tendered by an affiliate of the landlord. This strategic move is part of Relay's plan to relocate to Kendall Square, where they will lease 12,190 square feet of office space, resulting in a substantial reduction of approximately $16 million in rent expenses over the lease term. The transition involves a relocation payment of $3.5 million and the transfer of certain assets to the landlord. The company continues to operate its corporate headquarters at 60 Hampshire Street, Cambridge.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relay Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-134908), on June 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10